$673K of planned sales filed in 30 days · 0.1% of the units outstanding
Filed 10/01
Health care sectorNasdaq
$673K of planned sales filed in 30 days · 0.1% of the units outstanding
10/12 estimated earnings
112 13F filers hold it · −2 against the quarter before · shares held −1.6%
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
Staffan EncrantzDirector | Open-market buy | 06/10 | 06/11 | 14,100 sh | $4.88 | $68,808 | +1.0% |
Alison BauerleinChief Operating Officer | Open-market sale10b5-1 plan | 05/18 | 05/19 | 12,728 sh | $5.12 | $65,167.36 | −1.8% |
Jeremy B. HaydenChief Legal Officer | Open-market sale10b5-1 plan | 04/06 | 04/09 | 13,761 sh | $3.55 | $48,851.55 | −3.6% |
James RodbergChief Financial Officer | Open-market sale10b5-1 plan | 04/06 | 04/09 | 7,231 sh | $3.55 | $25,670.05 | −3.0% |
David BadawiChief Technology Officer | Open-market sale10b5-1 plan | 04/02 | 04/03 | 8,168 sh | $3.48 | $28,424.64 | −0.4% |
Badawi PaulOfficer, Director | 29,653 sh | $268,332.96 | 10/01 | Filed 10/01 | |
Badawi DavidOfficer, Director | 7,797 sh | $70,555.84 | 10/01 | Filed 10/01 | |
Hayden Jeremy B.Former Officer | 2,746 sh | $24,768.92 | 10/01 | Filed 10/01 | |
Hayden Jeremy B.Former Officer | 22,254 sh | $208,051.65 | 09/30 | Filed 09/30 | |
Hayden Jeremy B.Former Officer | 12,219 sh | $101,265.74 | 09/04 | Filed 09/04 | |
Hayden Jeremy B.Former Officer | 13,253 sh | $109,974.72 | 09/01 | Filed 09/01 | |
Hayden Jeremy B.Former Officer | 12,014 sh | $97,841.48 | 08/17 | Filed 08/17 | |
Hayden Jeremy B.Former Officer | 48,000 sh | $395,878.84 | 08/14 | Filed 08/14 | |
Hayden Jeremy B.Former Officer | 2,500 sh | $20,762.5 | 08/13 | Filed 08/13 | |
Hayden Jeremy B.Former Officer | 16,302 sh | $133,307.09 | 08/12 | Filed 08/12 |